FDA Advisory Panel Rejects Widespread Pfizer Vaccine Booster Shots
HuffPost
The panel did, however, endorse the extra shots for those who are 65 or older or at high risk of severe disease.
WASHINGTON (AP) — An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe disease.
The twin votes Friday represented a heavy blow to the Biden administration’s sweeping effort to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant.
The decision was made by a committee of outside experts who advise the Food and Drug Administration.
More Related News